Treatment of IBD is complex and based on different drugs. The biological treatments act on different stages of immunophysiopathological processes of the disease to change the evolution or natural history. At present the most studied and used biological drug is a chimerical monoclonal antibody to TNF alpha known as infliximab
Accomando, S., Albino, C., Di Fiore, A., Ferraro, F., Maniscalchi, V., Corsello, G. (2012). INFLIXIMAB THERAPY IN MANAGING PEDIATRIC IBD. DIGESTIVE AND LIVER DISEASE.
INFLIXIMAB THERAPY IN MANAGING PEDIATRIC IBD
ACCOMANDO, Salvatore;CORSELLO, Giovanni
2012-01-01
Abstract
Treatment of IBD is complex and based on different drugs. The biological treatments act on different stages of immunophysiopathological processes of the disease to change the evolution or natural history. At present the most studied and used biological drug is a chimerical monoclonal antibody to TNF alpha known as infliximab
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
XIX_SIGENP_abstracts.pdf
accesso aperto
Descrizione: Abstract PO40 S275
Dimensione
2.54 MB
Formato
Adobe PDF
|
2.54 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
